146 related articles for article (PubMed ID: 7228867)
1. Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells.
Nawata H; Bronzert D; Lippman ME
J Biol Chem; 1981 May; 256(10):5016-21. PubMed ID: 7228867
[TBL] [Abstract][Full Text] [Related]
2. Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.
Nawata H; Chong MT; Bronzert D; Lippman ME
J Biol Chem; 1981 Jul; 256(13):6895-902. PubMed ID: 7240250
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
4. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
5. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
6. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line.
Bronzert DA; Triche TJ; Gleason P; Lippman ME
Cancer Res; 1984 Sep; 44(9):3942-51. PubMed ID: 6744309
[TBL] [Abstract][Full Text] [Related]
8. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
Bronzert DA; Greene GL; Lippman ME
Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of buserelin, estradiol and tamoxifen on the growth of MCF-7 human breast cancer cells in vitro.
Foekens JA; Henkelman MS; Fukkink JF; Blankenstein MA; Klijn JG
Biochem Biophys Res Commun; 1986 Oct; 140(2):550-6. PubMed ID: 3096324
[TBL] [Abstract][Full Text] [Related]
11. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro.
Paulsen GH; Strickert T; Marthinsen AB; Lundgren S
Acta Oncol; 1996; 35(8):1011-9. PubMed ID: 9023387
[TBL] [Abstract][Full Text] [Related]
12. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.
Roos W; Oeze L; Löser R; Eppenberger U
J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.
Hu XF; Veroni M; De Luise M; Wakeling A; Sutherland R; Watts CK; Zalcberg JR
Int J Cancer; 1993 Nov; 55(5):873-6. PubMed ID: 8244585
[TBL] [Abstract][Full Text] [Related]
14. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
Lippman ME; Do HM; Hochberg RB
Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
[TBL] [Abstract][Full Text] [Related]
15. Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.
Gibson DF; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC
Breast Cancer Res Treat; 1993; 25(2):141-50. PubMed ID: 8347846
[TBL] [Abstract][Full Text] [Related]
16. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
Herman ME; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1.
Lykkesfeldt AE; Sørensen EK
Acta Oncol; 1992; 31(2):131-8. PubMed ID: 1622627
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
Vignon F; Bardon S; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
[TBL] [Abstract][Full Text] [Related]
19. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
Briand P; Lykkesfeldt AE
Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
[TBL] [Abstract][Full Text] [Related]
20. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
